Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

High intensity interval training improves physical performance in aged female mice: A comparison of mouse frailty assessment tools.

Seldeen KL, Redae YZ, Thiyagarajan R, Berman RN, Leiker MM, Troen BR.

Mech Ageing Dev. 2019 Jun;180:49-62. doi: 10.1016/j.mad.2019.04.001. Epub 2019 Apr 2.

PMID:
30951786
2.

AP-1 and Mitf interact with NFATc1 to stimulate cathepsin K promoter activity in osteoclast precursors.

Pang M, Rodríguez-Gonzalez M, Hernandez M, Recinos CC, Seldeen KL, Troen BR.

J Cell Biochem. 2019 Aug;120(8):12382-12392. doi: 10.1002/jcb.28504. Epub 2019 Feb 28.

PMID:
30816596
3.

Treatment with an inhibitor of fatty acid synthase attenuates bone loss in ovariectomized mice.

Bermeo S, Al Saedi A, Vidal C, Khalil M, Pang M, Troen BR, Myers D, Duque G.

Bone. 2019 May;122:114-122. doi: 10.1016/j.bone.2019.02.017. Epub 2019 Feb 16.

PMID:
30779961
4.

Short Session High Intensity Interval Training and Treadmill Assessment in Aged Mice.

Seldeen KL, Redae YZ, Thiyagarajan R, Berman RN, Leiker MM, Troen BR.

J Vis Exp. 2019 Feb 2;(144). doi: 10.3791/59138.

PMID:
30774134
5.

Absence of complement factor H alters bone architecture and dynamics.

Alexander JJ, Sankaran JS, Seldeen KL, Thiyagarajan R, Jacob A, Quigg RJ, Troen BR, Judex S.

Immunobiology. 2018 Dec;223(12):761-771. doi: 10.1016/j.imbio.2018.07.023. Epub 2018 Aug 1.

PMID:
30107932
6.

Chronic vitamin D insufficiency impairs physical performance in C57BL/6J mice.

Seldeen KL, Pang M, Leiker MM, Bard JE, Rodríguez-Gonzalez M, Hernandez M, Sheridan Z, Nowak N, Troen BR.

Aging (Albany NY). 2018 Jun 14;10(6):1338-1355. doi: 10.18632/aging.101471.

7.

Methamphetamine Induces Apoptosis of Microglia via the Intrinsic Mitochondrial-Dependent Pathway.

Sharikova AV, Quaye E, Park JY, Maloney MC, Desta H, Thiyagarajan R, Seldeen KL, Parikh NU, Sandhu P, Khmaladze A, Troen BR, Schwartz SA, Mahajan SD.

J Neuroimmune Pharmacol. 2018 Sep;13(3):396-411. doi: 10.1007/s11481-018-9787-4. Epub 2018 Apr 11.

PMID:
29644532
8.

Neuropeptide Y Y2 antagonist treated ovariectomized mice exhibit greater bone mineral density.

Seldeen KL, Halley PG, Volmar CH, Rodríguez MA, Hernandez M, Pang M, Carlsson SK, Suva LJ, Wahlestedt C, Troen BR, Brothers SP.

Neuropeptides. 2018 Feb;67:45-55. doi: 10.1016/j.npep.2017.11.005. Epub 2017 Nov 7.

9.

High Intensity Interval Training Improves Physical Performance and Frailty in Aged Mice.

Seldeen KL, Lasky G, Leiker MM, Pang M, Personius KE, Troen BR.

J Gerontol A Biol Sci Med Sci. 2018 Mar 14;73(4):429-437. doi: 10.1093/gerona/glx120.

PMID:
28633487
10.

A mouse model of vitamin D insufficiency: is there a relationship between 25(OH) vitamin D levels and obesity?

Seldeen KL, Pang M, Rodríguez-Gonzalez M, Hernandez M, Sheridan Z, Yu P, Troen BR.

Nutr Metab (Lond). 2017 Mar 11;14:26. doi: 10.1186/s12986-017-0174-6. eCollection 2017.

11.

Statement of Principle.

Troen BR, Ouslander JG, Yoshikawa T.

J Am Geriatr Soc. 2015 Aug;63(8):1693. doi: 10.1111/jgs.13589. No abstract available.

PMID:
26289687
12.

Mouse Models of Frailty: an Emerging Field.

Seldeen KL, Pang M, Troen BR.

Curr Osteoporos Rep. 2015 Oct;13(5):280-6. doi: 10.1007/s11914-015-0283-y. Review.

PMID:
26243670
13.

Do vitamin D levels influence the risk of diabetes mellitus and play a role in healthier aging?

Florez H, Troen BR.

J Am Geriatr Soc. 2011 Oct;59(10):1957-9. doi: 10.1111/j.1532-5415.2011.03592.x. No abstract available.

PMID:
22091507
14.

Retinoic acid inhibits NFATc1 expression and osteoclast differentiation.

Balkan W, Rodríguez-Gonzalez M, Pang M, Fernandez I, Troen BR.

J Bone Miner Metab. 2011 Nov;29(6):652-61. doi: 10.1007/s00774-011-0261-0. Epub 2011 Mar 8.

PMID:
21384111
15.

The response of elderly veterans to daily vitamin D3 supplementation of 2,000 IU: a pilot efficacy study.

Cherniack EP, Florez HJ, Hollis BW, Roos BA, Troen BR, Levis S.

J Am Geriatr Soc. 2011 Feb;59(2):286-90. doi: 10.1111/j.1532-5415.2010.03242.x. Epub 2011 Feb 2.

PMID:
21288233
16.

Treatment for osteoporosis in Australian residential aged care facilities: consensus recommendations for fracture prevention.

Duque G, Close JJ, de Jager JP, Ebeling PR, Inderjeeth C, Lord S, McLachlan AJ, Reid IR, Troen BR, Sambrook PN.

Med J Aust. 2010 Aug 2;193(3):173-9.

PMID:
20678047
17.

The cathepsin L gene is a direct target of FOXO1 in skeletal muscle.

Yamazaki Y, Kamei Y, Sugita S, Akaike F, Kanai S, Miura S, Hirata Y, Troen BR, Kitamura T, Nishino I, Suganami T, Ezaki O, Ogawa Y.

Biochem J. 2010 Mar 15;427(1):171-8. doi: 10.1042/BJ20091346.

PMID:
20088826
18.

Identification of NFAT binding sites that mediate stimulation of cathepsin K promoter activity by RANK ligand.

Balkan W, Martinez AF, Fernandez I, Rodriguez MA, Pang M, Troen BR.

Gene. 2009 Oct 15;446(2):90-8. doi: 10.1016/j.gene.2009.06.013. Epub 2009 Jun 27.

PMID:
19563866
19.

Prevention and treatment of senile osteoporosis and hip fractures.

Duque G, Demontiero O, Troen BR.

Minerva Med. 2009 Feb;100(1):79-94. Review.

PMID:
19277006
20.

Some new food for thought: the role of vitamin D in the mental health of older adults.

Cherniack EP, Troen BR, Florez HJ, Roos BA, Levis S.

Curr Psychiatry Rep. 2009 Feb;11(1):12-9. Review.

PMID:
19187703
21.

Hypovitaminosis D in the elderly: from bone to brain.

Cherniack EP, Florez H, Roos BA, Troen BR, Levis S.

J Nutr Health Aging. 2008 Jun-Jul;12(6):366-73. Review. No abstract available.

PMID:
18548173
22.

Understanding the mechanisms of senile osteoporosis: new facts for a major geriatric syndrome.

Duque G, Troen BR.

J Am Geriatr Soc. 2008 May;56(5):935-41. doi: 10.1111/j.1532-5415.2008.01764.x. Review. Erratum in: J Am Geriatr Soc. 2008 Jul;56(7):1378.

PMID:
18454751
23.

Hypovitaminosis D: a widespread epidemic.

Cherniack EP, Levis S, Troen BR.

Geriatrics. 2008 Apr;63(4):24-30.

PMID:
18376898
24.

Fat and inflammaging: a dual path to unfitness in elderly people?

Florez H, Troen BR.

J Am Geriatr Soc. 2008 Mar;56(3):558-60. doi: 10.1111/j.1532-5415.2007.01584.x. No abstract available.

PMID:
18315667
25.

Emerging therapies to treat frailty syndrome in the elderly.

Cherniack EP, Florez HJ, Troen BR.

Altern Med Rev. 2007 Sep;12(3):246-58.

26.

Functional grouping of osteoclast genes revealed through microarray analysis.

Yang G, Zaidi M, Zhang W, Zhu LL, Li J, Iqbal J, Varbanov A, Gross G, Phipps R, Troen BR, Sun L.

Biochem Biophys Res Commun. 2008 Feb 8;366(2):352-9. Epub 2007 Dec 3.

PMID:
18060857
27.

AP-1 stimulates the cathepsin K promoter in RAW 264.7 cells.

Pang M, Martinez AF, Fernandez I, Balkan W, Troen BR.

Gene. 2007 Nov 15;403(1-2):151-8. Epub 2007 Aug 25.

PMID:
17897792
28.

The regulation of cathepsin K gene expression.

Troen BR.

Ann N Y Acad Sci. 2006 Apr;1068:165-72. Review.

PMID:
16831915
29.

Osteoporosis in older people: a tale of two studies (and three treatments).

Troen BR.

J Am Geriatr Soc. 2006 May;54(5):853-5. No abstract available.

PMID:
16696755
30.

RANK ligand and interferon gamma differentially regulate cathepsin gene expression in pre-osteoclastic cells.

Pang M, Martinez AF, Jacobs J, Balkan W, Troen BR.

Biochem Biophys Res Commun. 2005 Mar 18;328(3):756-63.

PMID:
15694411
31.

RANK-L induces the expression of NFATc1, but not of NFkappaB subunits during osteoclast formation.

Zhu LL, Zaidi S, Moonga BS, Troen BR, Sun L.

Biochem Biophys Res Commun. 2005 Jan 7;326(1):131-5.

PMID:
15567162
32.

The role of cathepsin K in normal bone resorption.

Troen BR.

Drug News Perspect. 2004 Jan-Feb;17(1):19-28. Review.

PMID:
14993931
33.

Molecular mechanisms underlying osteoclast formation and activation.

Troen BR.

Exp Gerontol. 2003 Jun;38(6):605-14. Review.

PMID:
12814795
34.

The biology of aging.

Troen BR.

Mt Sinai J Med. 2003 Jan;70(1):3-22. Review.

PMID:
12516005
35.

Molecular cloning, expression, and function of osteoclastic calcineurin Aalpha.

Sun L, Moonga BS, Lu M, Zaidi N, Iqbal J, Blair HC, Epstein S, Abe E, Troen BR, Huang CL, Zaidi M.

Am J Physiol Renal Physiol. 2003 Mar;284(3):F575-83. Epub 2002 Nov 5.

36.

New insights into the regulation of cathepsin K gene expression by osteoprotegerin ligand.

Corisdeo S, Gyda M, Zaidi M, Moonga BS, Troen BR.

Biochem Biophys Res Commun. 2001 Jul 13;285(2):335-9.

PMID:
11444847
37.

Macrophage colony-stimulating factor suppresses osteoblast formation.

Gyda M, Corisdeo S, Zaidi M, Troen BR.

Biochem Biophys Res Commun. 2001 Jul 13;285(2):328-34.

PMID:
11444846
38.

Transcription of human cathepsin B is mediated by Sp1 and Ets family factors in glioma.

Yan S, Berquin IM, Troen BR, Sloane BF.

DNA Cell Biol. 2000 Feb;19(2):79-91.

PMID:
10701774
39.

Differentiating agents regulate cathepsin B gene expression in HL-60 cells.

Berquin IM, Yan S, Katiyar K, Huang L, Sloane BF, Troen BR.

J Leukoc Biol. 1999 Oct;66(4):609-16.

40.

CD38/ADP-ribosyl cyclase: A new role in the regulation of osteoclastic bone resorption.

Sun L, Adebanjo OA, Moonga BS, Corisdeo S, Anandatheerthavarada HK, Biswas G, Arakawa T, Hakeda Y, Koval A, Sodam B, Bevis PJ, Moser AJ, Lai FA, Epstein S, Troen BR, Kumegawa M, Zaidi M.

J Cell Biol. 1999 Sep 6;146(5):1161-72. Erratum in: J Cell Biol 1999 Sep 20;146(6):following 1399.

41.

The Gene Construction Kit. DNA sequence analysis and presentation.

Troen BR.

Methods Mol Biol. 1997;70:257-72. No abstract available.

PMID:
9089619
43.
44.

Phorbol ester stimulated cathepsin L expression in U937 cells.

Atkins KB, Troen BR.

Cell Growth Differ. 1995 Jun;6(6):713-8.

45.

Cloning, genomic organization, and chromosomal localization of human cathepsin L.

Chauhan SS, Popescu NC, Ray D, Fleischmann R, Gottesman MM, Troen BR.

J Biol Chem. 1993 Jan 15;268(2):1039-45.

46.

Downstream sequences mediate induction of the mouse cathepsin L promoter by phorbol esters.

Troen BR, Chauhan SS, Ray D, Gottesman MM.

Cell Growth Differ. 1991 Jan;2(1):23-31.

47.
49.
50.

Colony screening of genomic cosmid libraries.

Troen BR.

Methods Enzymol. 1987;151:416-26. No abstract available.

PMID:
3323799

Supplemental Content

Loading ...
Support Center